Pathological sub-analysis of a multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy versus steroid pulse monotherapy in patients with immunoglobulin A nephropathy

[1] Hotta O(2001)Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy Am J Kidney Dis 38 736-743

[2] Miyazaki M(2009)Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy Clin Exp Nephrol 13 460-466

[3] Furuta T(2013)Nationwide survey on current treatments for IgA nephropathy in Japan Clin Exp Nephrol 17 827-833

[4] Miura N(2012)A treatment dilemma in adult immunoglobulin A nephropathy: what is the appropriate target, preservation of kidney function or induction of clinical remission? Clin Exp Nephrol 16 195-201

[5] Imai H(2006)IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors Nat Clin Pract Nephrol. 2 24-31

[6] Kikuchi S(2006)The IgA nephropathy treatment dilemma Kidney Int 69 1939-1944

[7] Matsuzaki K(2014)Special IgA Nephropathy Study Group. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy Nephrol Dial Transplant 29 1546-1553

[8] Suzuki Y(2009)Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 982-992

[9] Nakata J(2013)Special IgA Nephropathy Study Group. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease J Nephrol 26 350-357

[10] Imai H(2001)Predicting progression in IgA nephropathy Am J Kidney Dis 38 728-735

[1] Hotta O(2001)Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy Am J Kidney Dis 38 736-743

[2] Miyazaki M(2009)Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy Clin Exp Nephrol 13 460-466

[3] Furuta T(2013)Nationwide survey on current treatments for IgA nephropathy in Japan Clin Exp Nephrol 17 827-833

[4] Miura N(2012)A treatment dilemma in adult immunoglobulin A nephropathy: what is the appropriate target, preservation of kidney function or induction of clinical remission? Clin Exp Nephrol 16 195-201

[5] Imai H(2006)IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors Nat Clin Pract Nephrol. 2 24-31

[6] Kikuchi S(2006)The IgA nephropathy treatment dilemma Kidney Int 69 1939-1944

[7] Matsuzaki K(2014)Special IgA Nephropathy Study Group. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy Nephrol Dial Transplant 29 1546-1553

[8] Suzuki Y(2009)Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 982-992

[9] Nakata J(2013)Special IgA Nephropathy Study Group. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease J Nephrol 26 350-357

[10] Imai H(2001)Predicting progression in IgA nephropathy Am J Kidney Dis 38 728-735